🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Final dispatch from the Canary Islands.🚨 Tune in for a dynamic discussion as Dr. Elena Castro of Virgen de la Victoria University Hospital in Malaga, Spain joins Tom and Brian the day after 177 Lu-PSMA’s pre-chemotherapy approval to discuss the PSMAFore data and application in

Who’s next? 👀 Ithaca Bomber Football

PEACE3: Early use of bone protecting agent (BPA) w Enza ± Radium 223 improved rPFS & OS. n=119 stratified according to use of BPA. 🟡 BPA improved rPFS by 14m (27m vs 13m, HR=0.60, 95%CI 0.39-0.93) ✅ 🟠 BPA improved OS by 17m (43m vs 26m, HR=0.56, 95%CI 0.37-0.86)✅

TAR-200 Monotherapy in Patients With Bacillus Calmette-Guérin–Unresponsive High- Risk Non–Muscle-Invasive Bladder Cancer Carcinoma in Situ: 1-Year Durability #MedIQAUA25 #AUA25 #bladdercancer

🚨 New episode alert! Joe Jacob joins the show to discuss the longer-term follow up of this cohort from SunRISe-1. We discuss definitions of CR and regulatory issues around drug approval in this space as well. 🎙️ GU Oncology Now: buff.ly/N5cAT6F 🍎 Apple Podcasts:

🚨 New episode alert! silke gillessen and Christopher Sweeney, MBBS join us to discuss our latest 'Uromigos Score' in which experts score the value of treatments for advanced prostate cancer. Expect some interesting themes and insights. 🎙️ GU Oncology Now: buff.ly/GzQAw1J 🍎

AMPLITUDE trial #ASCO25 AttardLab OncoAlert increases rPFS for niraparib (PARPi) + ARPI (Abi) in mCSPC with + BRCA/HRR (HR-0.53/0.63) & a trend toward improved OS (HR0.75/0.79). This moves PARPi into 1st line and supports personalised approaches in 1st line RCC

#FDA approves darolutamide for metastatic castration-sensitive #prostatecancer U.S. FDA ASCO Advanced Prostate Cancer Consensus Conference OncoAlert #ASCO25 Uromigos Oncology Brothers

Just in time as Darolutamide is now also U.S. FDA approved for mHSPC based off ARANOTE study - Ph III, metastatic (by bone scan or CT/MRI) hormone-sensitive prostate cancer. - rPFS NR (statistically significant) but OS (not statistically significant) #OncTwitter #MedTwitter

I had a great time competing at the AVC Mega Football Camp at Kean University yesterday. I Appreciate all the coaches Thank you!! Anthony Van Curen Mustangs Football Madei Williams 🔌 Joe Mento

❗️ This just in: The U.S. FDA has approved the use of #darolutamide for the treatment of metastatic #prostatecancer: buff.ly/dnj9wAT 👉 The approval is based on positive results of the ARANOTE study, which compared darolutamide with placebo in patients with metastatic

🚨 New episode alert! Listen in on some of the breakthroughs and progress discussed this year during ASCO 2025. In this episode, Dr. Michiel Van Der Heijden joins the Uromigos to discuss the ipilimumab + nivolumab vs. chemotherapy randomization in this trial from his ASCO 2025

It’s no NFL or College Football but amazing things are happening in the CFL

The 4th live Uromigos meeting is happening on 7th & 8th Nov ‘25 in Nashville. It’s going to have an international flavour with America’s 🇺🇸 🇨🇦 vs Eurasia 🇯🇵 🇨🇳 🇮🇳 🇦🇺 🇪🇺 Uromigos Cup competition (details to follow). Sessions ranging from ADCs in MIBC to the changing shape of

Great time competing with my teammates Mustangs Football at the Wayne Valley Football 7v7 Shootout yesterday! The seperation is in the preparation! Mustangs Football Madei Williams 🔌 Joe Mento Brett Kunkel Coach Brendan Dante Palladino Luke Guilbert joey beyer ricky beyer Ryan Conlon